三门峡腋下狐臭开刀治疗三门峡小女孩 腋臭,三门峡三门峡祛除疤痕疙瘩医院哪,在三门峡治疗狐臭微创,三门峡最好狐臭治疗医院,三门峡怎么样治疗面部痘痘,三门峡痘痘治疗价格,痤疮 三门峡哪家医院比较好

WASHINGTON, Nov. 16 (Xinhua) -- Data from NASA's Galileo spacecraft have provided scientists evidence of what appears to be a body of liquid water, equal in volume to the North American Great Lakes, beneath the icy surface of Jupiter's moon, Europa, the U.S. space agency announced Wednesday.The data suggest there is significant exchange between Europa's icy shell and the ocean beneath. This information could bolster arguments that Europa's global subsurface ocean represents a potential habitat for life elsewhere in our solar system. The findings will be published Thursday in the scientific journal Nature.Europa, which is slightly smaller than Earth's moon, is believed to have a large ocean of salty water deep beneath its frozen crust. Galileo spacecraft, launched by the space shuttle Atlantis in 1989, studied Jupiter, which is the most massive planet in the solar system, and some of its many moons.Pictures of it sent back by Galileo point to a tortured surface of cracks and jumbled ice. Seeking to understand how such weird topography evolved in a place with such dim sunlight, scientists believe that the answer lies in similar processes on Earth.Their model suggests that Europa's ice shell is about 10 kilometers thick and within it are giant pockets of water, lying at depths as shallow as three kilometers. Warm water from these sub-surface lakes wells up in plumes, causing the ice to become brittle, crack and then collapse. The ice turnover would be a plus for the prospects for life, as it would transfer energy and nutrients between the sub-glacial lake and the surface."One opinion in the scientific community has been if the ice shell is thick, that's bad for biology. That might mean the surface isn't communicating with the underlying ocean," said Britney Schmidt, lead author of the paper and postdoctoral fellow at the Institute for Geophysics, University of Texas at Austin. " Now, we see evidence that it's a thick ice shell that can mix vigorously and new evidence for giant shallow lakes. That could make Europa and its ocean more habitable.""The data opens up some compelling possibilities," said Mary Voytek, director of NASA's Astrobiology Program. "However, scientists worldwide will want to take a close look at this analysis and review the data before we can fully appreciate the implication of these results."

BEIJING, Oct. 28 (Xinhuanet) -- Taking aspirin everyday may lower the risk of developing colon cancer for people with the cancer-causing genes, researchers found.The finding was published on Friday in the British medical journal "Lancet".The researchers followed 508 patients with Lynch syndrome, an inherited disorder which increases the risk of developing colon and other cancers.These patients were divided into two groups: members in one group took 600 mg aspirins everyday; another group took only the dummy pills.After 4 years, 10 colon cancer cases were reported among 258 patients who took daily aspirins for at least two years, comparing with 23 cases among 250 patients on dummy pills."This is good news for a very specific population," said Asad Umar, a cancer prevention expert at the U.S. National Cancer Institute.However, the finding doesn't apply to the general public, suggested the lead author of the study John Burn, a geneticist at Newcastle University in England.Only those who are at risk of such diseases should consider taking aspirin regularly, such as people having a family history of colon cancer, he added.

WASHINGTON, Dec. 7 (Xinhua) -- The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.Their report, published on-line Wednesday in Gynecologic Oncology, suggests that this combination, ixabepilone and sunitinib, might offer a much needed treatment option for women with advanced ovarian cancer.Neither drug is approved for use in ovarian cancer. Ixabepilone is a chemotherapy drug that, like other taxane drugs, targets the microtubules and stops dividing cells from forming a spindle. It has been approved for use in metastatic breast cancer. Sunitinib, approved for use in kidney cancer, belongs to a class of tyrosine kinase inhibitors that stops growth signals from reaching inside cancer cells.When caught at late stages, ovarian cancer is often fatal because it progressively stops responding to the chemotherapy drugs used to treat it."Women die from ovarian cancer because their tumors become resistant to chemotherapy, so a drug that might be able to reduce that resistance -- which may be what this combination of agents is doing -- would be a boon to treatment of this difficult cancer," says study coauthor Gerardo Colon-Otero.The finding also highlights the importance of the role of a molecule, RhoB, that the researchers say is activated by the drug duo. It might be a potential biomarker that may help identify patients who might benefit from such combination therapy, the researchers say.

SHANGHAI, Jan. 11 (Xinhua) -- The listed arm of China's biggest train maker, China South Locomotive and Rolling Stock Industry (Group) Corporation (CSR), has been allowed by regulatory authorities to raise 9 billion yuan (1.41 billion U.S. dollars) on the stock market, the company said Wednesday.The Hong Kong- and Shanghai- listed CSR Corp. Ltd. will sell 1.96 billion shares at 4.46 yuan apiece to select investors, it said. But CSR's parent -- state-owned CSR Group -- has agreed to buy no less than 6 billion yuan's worth of the shares, leaving the rest to institutional investors.CSR's net profit growth in the third quarter of 2011 plunged to 9.66 percent year-on-year from a high of 85.08 percent in the first half of 2011 as the country put the brakes on development of the railway sector after a deadly bullet train crash on July 23 that killed 40 people and injured 210 others.The decision to slow the development of high-speed rail lines has led to halts in construction of about 90 percent of ongoing railway projects, or 10,000 km of rail lines across the country, local media reported earlier.CSR is the maker of the bullet trains involved in last July's deadly collision. After the accident, the company's executives bought a combined 540,000 share in August, a move seen as an attempt to bolster battered stock prices.Analysts say the fundraising would help CSR greatly ease its financial burdens. The company earlier pledged to maintain profit growth and its dividend policy to boost investors' confidence.

NANJING, Dec. 8 (Xinhua) -- Chinese stargazers will have their best view of a total lunar eclipse in 10 years on Saturday if weather permits, the Zijinshan Astronomical Observatory under the Chinese Academy of Sciences (CAS) said Thursday.Wang Sichao, a research fellow with the observatory, said during the total eclipse, the full moon will not completely disappear from the Earth's shadow, but will take on a brilliant bronze color.He said the eclipse will be the best one seen in China since the last one occurred on Jan. 10, 2001."Theoretically, viewers can observe the eclipse from nearly everywhere in the country on Saturday," said the astronomer.He said the eclipse, the second this year, will last for 51 minutes. It will start at 8:45 p.m. and reach its climax at 10:06 p.m.Wang said Chinese viewers will have to wait until Oct. 8, 2014 to see the next total lunar eclipse.